CoChat

VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation

Open access
Grieder, Taryn E, Herman, Melissa A, Contet, Candice, Tan, Laura A, Vargas-Perez, Hector, Cohen, Ami, Chwalek, Michal, Maal-Bared, Geith, Freiling, John, Schlosburg, Joel E, Clarke, Laura, Crawford, Elena, Koebel, Pascale, Repunte-Canonigo, Vez, P Sanna, Pietro, Tapper, Andrew R, Roberto, Marisa, Kieffer, Brigitte L, Sawchenko, Paul E, Koob, George F, van der Kooy, Derek, George, Olivier · 2014 · Nature Neuroscience
Cited by 132

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Dopaminergic neurons in the ventral tegmental area (VTA) are well known for mediating the positive reinforcing effects of drugs of abuse. Here we identify in rodents and humans a population of VTA dopaminergic neurons expressing corticotropin-releasing factor (CRF). We provide further evidence in rodents that chronic nicotine exposure upregulates Crh mRNA (encoding CRF) in dopaminergic neurons of the posterior VTA, activates local CRF1 receptors and blocks nicotine-induced activation of transient GABAergic input to dopaminergic neurons. Local downregulation of Crh mRNA and specific pharmacological blockade of CRF1 receptors in the VTA reversed the effect of nicotine on GABAergic input to dopaminergic neurons, prevented the aversive effects of nicotine withdrawal and limited the escalation of nicotine intake. These results link the brain reward and stress systems in the same brain region to signaling of the negative motivational effects of nicotine withdrawal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.3872

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Koob, G.F. & Le Moal, M. Addiction and the brain antireward system. Annu. Rev. Psychol. 59, 29–53 (2008). · DOI · Paper page
  2. Koob, G.F. & Volkow, N.D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217–238 (2010). · DOI · Paper page
  3. Sarnyai, Z., Shaham, Y. & Heinrichs, S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53, 209–243 (2001). · DOI · Paper page
  4. Picciotto, M.R. & Kenny, P.J. Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb. Perspect. Med. 3, a012112 (2013). · DOI · Paper page
  5. Boyson, C.O., Miguel, T.T., Quadros, I.M., Debold, J.F. & Miczek, K.A. Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berl.) 218, 257–269 (2011). · DOI · Paper page
  6. Hahn, J., Hopf, F.W. & Bonci, A. Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J. Neurosci. 29, 6535–6544 (2009). · DOI · Paper page
  7. Wanat, M.J., Bonci, A. & Phillips, P.E. CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat. Neurosci. 16, 383–385 (2013). · DOI · Paper page
  8. Wang, B., You, Z.B., Rice, K.C. & Wise, R.A. Stress-induced relapse to cocaine seeking: roles for the CRF2 receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl.) 193, 283–294 (2007). · DOI · Paper page
  9. Wang, H.L. & Morales, M. Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J. Comp. Neurol. 509, 302–318 (2008). · DOI · Paper page
  10. Blacktop, J.M. et al. Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J. Neurosci. 31, 11396–11403 (2011). · DOI · Paper page
  11. Vranjkovic, O., Gasser, P.J., Gerndt, C.H., Baker, D.A. & Mantsch, J.R. Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J. Neurosci. 34, 12504–12514 (2014). · DOI · Paper page
  12. Grieder, T.E. et al. Dopaminergic signaling mediates the motivational response underlying the opponent motivational process to chronic but not acute nicotine. Neuropsychopharmacology 35, 943–954 (2010). · DOI
  13. Grieder, T.E. et al. Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal. Proc. Natl. Acad. Sci. USA 109, 3101–3106 (2012). · DOI · Paper page
  14. Tagliaferro, P. & Morales, M. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J. Comp. Neurol. 506, 616–626 (2008). · DOI · Paper page
  15. Kozicz, T. et al. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J. Comp. Neurol. 519, 1413–1434 (2011). · DOI · Paper page
  16. Zhao-Shea, R. et al. Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36, 1021–1032 (2011). · DOI · Paper page
  17. Hnasko, T.S., Hjelmstad, G.O., Fields, H.L. & Edwards, R.H. Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J. Neurosci. 32, 15076–15085 (2012). · DOI · Paper page
  18. Nimitvilai, S., Arora, D.S., McElvain, M.A. & Brodie, M.S. Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors. Neuroscience 226, 29–39 (2012). · DOI
  19. Doyon, W.M. et al. Nicotine decreases ethanol-induced dopamine signaling and increases self-administration via stress hormones. Neuron 79, 530–540 (2013). · DOI · Paper page
  20. Cohen, A. et al. Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats. Addict. Biol. 10.1111/adb.12077 (2013). · DOI · Paper page
  21. Cohen, A., Koob, G.F. & George, O. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology 37, 2153–2160 (2012). · DOI
  22. Son, S.J. et al. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron 78, 1036–1049 (2013). · DOI · Paper page
  23. Treweek, J.B., Jaferi, A., Colago, E.E., Zhou, P. & Pickel, V.M. Electron microscopic localization of corticotropin-releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala. J. Comp. Neurol. 512, 323–335 (2009). · DOI
  24. Marcinkiewcz, C.A. et al. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 34, 1743–1752 (2009). · DOI · Paper page
  25. Torres, O.V., Gentil, L.G., Natividad, L.A., Carcoba, L.M. & O'Dell, L.E. Behavioral, biochemical, and molecular indices of stress are enhanced in female versus male rats experiencing nicotine withdrawal. Front. Psychiatry 4, 38 (2013). · DOI · Paper page
  26. Lodge, D.J. & Grace, A.A. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J. Pharmacol. Exp. Ther. 314, 201–206 (2005). · DOI
  27. Willuhn, I., Burgeno, L.M., Groblewski, P.A. & Phillips, P.E. Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat. Neurosci. 17, 704–709 (2014). · DOI · Paper page
  28. van Zessen, R., Phillips, J.L., Budygin, E.A. & Stuber, G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 73, 1184–1194 (2012). · DOI · Paper page
  29. Tan, K.R. et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 73, 1173–1183 (2012). · DOI · Paper page
  30. Nader, K. & van der Kooy, D. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J. Neurosci. 17, 383–390 (1997). · DOI · Paper page
  31. Vargas-Perez, H. et al. Ventral tegmental area BDNF induces an opiate-dependent like reward state in naive rats. Science 324, 1732–1734 (2009). · DOI · Paper page
  32. Laviolette, S.R., Alexson, T.O. & van der Kooy, D. Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J. Neurosci. 22, 8653–8660 (2002). · DOI · Paper page
  33. Steffensen, S.C. et al. Contingent and non-contingent effects of heroin on mu-opioid receptor-containing ventral tegmental area GABA neurons. Exp. Neurol. 202, 139–151 (2006). · DOI
  34. Richardson, H.N. et al. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol. Biochem. Behav. 88, 497–510 (2008). · DOI
  35. Darcq, E. et al. RSK2 signaling in brain habenula contributes to place aversion learning. Learn. Mem. 18, 574–578 (2011). · DOI
  36. Zolotukhin, S. et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158–167 (2002). · DOI · Paper page

Cited by

See all 132

Metadata

Authors
Grieder, T. E., Herman, M. A., Contet, C., Tan, L. A., Vargas-Perez, H., Cohen, A., Chwalek, M., Maal-Bared, G., Freiling, J., Schlosburg, J. E., Clarke, L., Crawford, E., Koebel, P., Repunte-Canonigo, V., P Sanna, P., Tapper, A. R., Roberto, M., Kieffer, B. L., Sawchenko, P. E., Koob, G. F., van der Kooy, D., & George, O.
Venue
Nature Neuroscience
Published
2014-11-17
Volume
17
Issue
12
Pages
1751-1758
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2087164445
Cited by
132
References
16
FWCI
6.71
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.